Drawing for EUROIMMUN

USPTO serial 79226820

EUROIMMUN

Reviewed by CopyMark Law Group

Reg. 5582980Status 708Registered
Filing date
Status date
Registration date
Oct 16, 2018
Examiner
FLETCHER, TRACY L
Law office
Historical data usage

What this means

This trademark is registered with the USPTO. Monitoring new filings can help you catch lookalike marks early.

Need help with EUROIMMUN?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Kevan L. Morgan

Kevan L. Morgan Seed IP Law Group LLP701 Fifth AvenueSuite 5400Seattle, WA 98104

Goods and services

ClassDescriptionStatusFirst use
001Diagnostic preparations, other than for medical or veterinary purposes; diagnostic preparations for scientific purposes, namely, immobilized proteins, nucleic acid sequences, allergens and biological tissue cultures; [ unprocessed synthetic resin compounds in the form of microspheres used to incorporate various other substances; ] chemical test paper; chemically-treated nonmedical test strips for use in for use in analyzing nucleic acids, proteins, cells and tissues; reagents for scientific and research use for labeling, sequencing and fragment analysis of nucleic acids and proteins; polymeric membranes in chemical form for the separation of liquid gas and patient samplesACTIVE—
005Diagnostic preparations for medical and veterinary purposes in the fields of neurological diseases, infectious diseases, autoimmune diseases, allergies and cancer; diagnostic preparations for medical and veterinary purposes; diagnostic agents for medical and veterinary purposes, namely immobilized proteins, nucleic acid sequences, allergens and biological tissue cultures; [ reagent paper for medical or veterinary purposes; ] medical diagnostic test strips for testing blood, urine and saliva in the diagnosis of neurological diseases, infectious diseases, autoimmune diseases, allergies and cancer; medical diagnostic reagents; biological and chemical preparations and reagents for medical or veterinary purposes, namely, cells for medical or clinical use, cultures of microorganisms for medical or veterinary use, protein arrays for medical diagnosis purposes, [ synthetic peptides for the treatment of neurological diseases, infectious diseases, autoimmune diseases, allergies and cancer ] and nucleic acid sequences for medical and veterinary purposesACTIVE—
009Measuring devices for measuring [ pressure, temperature, chemical compound concentrations and ] optical signals, such as fluorescence [ and chemiluminescence ] for diagnostic sample testing, not for medical use; [ sensors and detectors for testing UV fluorescence and chemiluminescence for diagnostic sample testing, not for medical use; ] laboratory apparatus for recording, transmission or reproduction of diagnostic data, [ sound or ] images, namely, [ cameras, ] microscopes, [ photometers, microplate photometers, ] ELISA (enzyme-linked immunosorbent assay) readers, [ photomultipliers ] and microplate readers; laboratory software for recording, transmitting and reproducing diagnostic data, [ sound ] and images; biochips for research or scientific purposes; plates having multi-well arrays that can be used in chemical analysis, biological analysis or patterning for scientific, laboratory or medical research useACTIVE—
010[ Medical apparatus and instruments for medical examinations and medical diagnosis, namely, flatbed CT scanners, drum CT scanners and hand-held X-ray scanners; medical apparatus and instruments for apheresis ]SECTION 71 - CANCELLED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Mar 27, 2026INPRPARTIAL INVALIDATION OF REG EXT PROTECTION CREATED—
Jul 27, 2025NA75NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED—
Jul 27, 2025C75PREGISTERED - PARTIAL SEC. 71 ACCEPTED & SEC. 15 ACK.—
Jul 14, 2025APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL—
Apr 14, 2025ES75TEAS SECTION 71 & 15 RECEIVED—
Oct 16, 2023REM3COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED—
Apr 12, 2019FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Jan 29, 2019XXSSGENERIC MADRID TRANSACTION SENT TO IB—
Jan 29, 2019XXCRGENERIC MADRID TRANSACTION CREATED—
Jan 16, 2019FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Oct 16, 2018R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Jul 31, 2018NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Jul 31, 2018PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jul 27, 2018GPNXNOTIFICATION PROCESSED BY IB—
Jul 11, 2018OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Jul 11, 2018NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Jul 11, 2018OP2RNOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB—
Jun 23, 2018CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jun 23, 2018TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jun 22, 2018CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jun 22, 2018ERFRTEAS REQUEST FOR RECONSIDERATION RECEIVED—
Jun 15, 2018CNFRFINAL REFUSAL MAILEDA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Jun 14, 2018CNFRFINAL REFUSAL WRITTENA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Jun 12, 2018TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jun 11, 2018CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jun 11, 2018TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Mar 24, 2018RFNTREFUSAL PROCESSED BY IB—
Mar 8, 2018RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Mar 8, 2018RFRRREFUSAL PROCESSED BY MPU—
Mar 2, 2018RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Mar 2, 2018MAFRAPPLICATION FILING RECEIPT MAILED—
Mar 1, 2018CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Feb 26, 2018DOCKASSIGNED TO EXAMINER—
Feb 26, 2018NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Feb 15, 2018REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance